Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
NCT05630729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67
Last updated 2022-11-30
Summary
Leveraging a unique combination of synchronized web and mobile applications, this 3 year SBIR Phase II project will fully develop and pilot test My Kidney Guru-a program that will offer pediatric patients with CKD developmentally appropriate, interactive, and engaging instruction and practice opportunities to build knowledge and skills to manage CKD.
Conditions
- Chronic Kidney Diseases
- Chronic Kidney Disease stage3
- Chronic Kidney Disease stage4
- Chronic Kidney Disease Stage V
- Chronic Kidney Disease Stage 5
- Chronic Kidney Disease Stage 2
- Chronic Kidney Disease, Stage I
- Chronic Kidney Disease, Stage IV (Severe)
- Pediatric Kidney Disease
Interventions
- OTHER
-
My Kidney Guru
My Kidney Guru is a program that will offer pediatric patients with CKD developmentally appropriate, interactive, and engaging instruction and practice opportunities to build knowledge and skills to manage CKD.
Sponsors & Collaborators
-
University of North Carolina, Chapel Hill
collaborator OTHER -
3-C Institute for Social Development
lead INDUSTRY
Principal Investigators
-
Debra Childress, PHD · 3- C Institute for Social Development, dba 3C Institute
-
Maria Ferris, MD, PHD, MPH · University of North Carolina, Chapel Hill
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 13 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-01
- Primary Completion
- 2022-07-31
- Completion
- 2022-07-31
Countries
- United States
Study Locations
More Related Trials
-
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
NCT06147232 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
NCT02194790 ·Status: COMPLETED ·Phase: NA
-
Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
NCT02176278 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT05004428 ·Status: COMPLETED
-
A Study of LY2623091 in Male and Females With Chronic Kidney Disease
NCT01427972 ·Status: COMPLETED ·Phase: PHASE2
-
Decision Impact Trial of KidneyIntelX
NCT04791358 ·Status: RECRUITING
-
A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
NCT01500798 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Participants With Diabetic Kidney Disease
NCT01113801 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
NCT02895750 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02312050 ·Status: UNKNOWN ·Phase: PHASE2
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease
NCT06236672 ·Status: COMPLETED
-
Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management
NCT06756113 ·Status: COMPLETED ·Phase: NA
-
A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)
NCT04445181 ·Status: COMPLETED
-
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302 ·Status: RECRUITING ·Phase: PHASE3
-
Mechanism of SGLT2 Inhibition in the Kidney
NCT06291155 ·Status: RECRUITING ·Phase: PHASE4
-
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
NCT06717698 ·Status: RECRUITING ·Phase: PHASE2
-
PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)
NCT00729365 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
NCT07271186 ·Status: RECRUITING ·Phase: PHASE2
-
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
NCT07280585 ·Status: RECRUITING ·Phase: PHASE3
-
Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics
NCT06948292 ·Status: COMPLETED ·Phase: PHASE2
-
Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes
NCT06925217 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function
NCT01759576 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus
NCT01030679 ·Status: COMPLETED ·Phase: PHASE2